A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

A

Albany College of Pharmacy and Health Sciences

Status and phase

Completed
Phase 4

Conditions

Obesity

Treatments

Drug: Orlistat

Study type

Interventional

Funder types

Other

Identifiers

NCT01035333
09-016

Details and patient eligibility

About

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

adult patients preparing for gastric bypass surgery

Exclusion criteria

pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

orlistat 60mg
Experimental group
Description:
Patients assigned to treatment group for up to 6 months of therapy.
Treatment:
Drug: Orlistat

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems